Columnist Jennifer Lynne recently attended the CHES Foundation's One Drop consortium, a powerful space for those with rare bleeding disorders.

Through the end of March, the Red Cross is offering all donors a free A1C test — a screening that measures average blood sugar levels and can detect early signs of pre-diabetes and diabetes.

CERS’ INTERCEPT platform (kits + illuminators) is scaling globally, with record 2025 results. They’ve also grown their ...

BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results ...

QC Kinetix uses the body’s natural healing properties with therapies such as Platelet-Rich Plasma and stem cell therapy to improve mobility ...

HUNTSVILLE, Ala. — LifeSouth Community Blood Centers says blood collections across North Alabama have dropped over the past week, leading to a reduced supply for local hospitals. Now, the organization ...

An early flu season coupled with winter storms has caused a nationwide blood shortage and led to the cancellation of some blood drives in Maine. American Red Cross officials are encouraging donors to ...

Autoimmune disease is often associated with an increased risk of thrombosis by a variety of mechanisms. As diagnostic techniques have advanced, the role of antibodies that target proteins involved in ...

View news about the Los Angeles Angels vs. Seattle Mariners game played on March 03, 2026 including player news, injury news, predictions, analysis and more.

This month, the American Red Cross of Utah is providing blood donors with free A1C blood sugar testing, which screens for diabetes and prediabetes. The organization’s previous data suggests as many as ...

Heparin-induced thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target complexes of platelet factor 4 (PF4) and heparin. HIT has been characterized as a ...

An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...